A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors.

ABSTRACT:

Objective

For early-stage cervical cancer patients experiencing radical surgery, postoperative radiotherapy was recommended for patients with a combination of intermediate-risk factors. However, there was no consensus on whether to administer concurrent chemotherapy. The aim of the study was to confirm the clinical value of the controlling nutritional status (CONUT) score in guiding the use of concurrent chemotherapy during postoperative radiotherapy.

Methods

A total of 969 patients with FIGO stage IB-IIA cervical cancer were retrospectively analyzed. Kaplan-Meier survival analysis was performed to compare disease-free survival (DFS) and cancer-specific survival (CSS) rates between different group. A Cox proportional hazards regression test was used to conduct multivariate a

SUBMITTER: Fu C 

PROVIDER: S-EPMC10300080 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature